Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol for Prevention of Cisplatin-induced Nephrotoxicity
NCT04251689Phase 3Completed
- Sponsor
- Phramongkutklao College of Medicine and Hospital
- Start
- Dec 2018
- Primary completion
- Jul 2020
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Bronchitol in cisplatin-induced nephrotoxicity (CIN), sponsored by Phramongkutklao College of Medicine and Hospital. Started Dec 2018; status: completed.
02
Drugs
Bronchitol
03
Conditions
cisplatin-induced nephrotoxicity (CIN)
Beyond the preview
Go deeper on NCT04251689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04251689.